Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin for prevention of hypertrophic scarring
IRCT20100314003566N15Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of neuronox in Hypertrophic Scar (HS), sponsored by Tabriz University of Medical Sciences. Started Jul 2024; status: completed.
02
Drugs
neuronox
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on IRCT20100314003566N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100314003566N15.